Introduction {#s1}
============

The application of *in vitro* fertilization (IVF) began 40 years ago. More than 5 million children have been born since then who simply could not have been without the development of IVF ([@B1]). With the accumulation of clinical experience and advancement of cryopreservation techniques, frozen embryo transfer (FET) has been widely used because of the higher pregnancy rate it resulted in and a trend for lower risks of preterm birth, low birth weight, and perinatal death compared to fresh embryo transfer (ET) ([@B2]--[@B4]).

Recently, a new strategy called "freeze-all" emerged in clinical treatment, which was confirmed to further improve the outcomes of IVF ([@B5]). By cryopreserving all embryos, ovarian hyper-stimulation syndrome (OHSS) in high-risk women could be initially avoided and a better embryo-endometrium synchrony achieved with endometrium preparation could provide a physiological environment for embryo implantation. Several observational studies showed the higher rates of pregnancy and live birth and better perinatal outcomes with the freeze-all strategy ([@B4], [@B6], [@B7]). A randomized controlled trial assigned 1,508 women with the polycystic ovary syndrome (PCOS) suggested that freeze-all strategy led to a higher live birth rate (49.3% vs. 42.0%; relative risk, 1.17; 95% CI, 1.05--1.31) and a lower pregnancy loss rate (2.0% vs. 32.7%; relative risk, 0.67; 95% CI, 0.54--0.83) than did fresh-embryo transfer ([@B8]). Another multicenter, randomized, controlled trial involving 2,157 ovulatory women indicated the risk of the OHSS in freeze-all group was significantly lower than that in fresh embryo transfer group (0.6% vs. 2.0%; relative risk, 0.32; 95% CI, 0.14--0.74) ([@B9]). As none of these studies were conducted in advanced endometriosis patients, the effect of freeze-all strategy in this aspect was still unknown. Only two studies on endometriosis-related infertility showed that freeze-all policy caused better pregnancy outcomes but with small sample sizes ([@B10], [@B11]). Additionally, the outcome of infants was lacking. Of note, previous study proved women with advanced endometriosis had lower rates of implantation, cumulative pregnancy, and live-birth compared with patients with mild endometriosis or tubal factor infertility ([@B12]). And to date, the best practice for treating stage III/IV endometriosis-related infertility is still a matter of debate in the medical community. It is extremely important to determine if there are any differences between the two procedures in fertility and neonatal outcomes.

Consequently, the aim of the present study is to assess the influence of freeze-all strategy, as compared with fresh embryo transfer, on pregnancy and neonatal outcomes in women with advanced endometriosis.

Materials and Methods {#s2}
=====================

Study Design
------------

The data in this study were obtained from the ART database at the Department of Assisted Reproduction of the Shanghai Ninth People\'s Hospital, affiliated with the Jiao Tong University School of Medicine between March 2006 and March 2017. Our study was approved by the hospital\'s Ethics Committee (Institutional Review Board). The following women were included: (1) diagnosed with endometriosis by laparoscopy and classified stage III to IV according to the revised American Society for Reproductive Medicine (ASRM) scoring system ([@B13]); (2) scheduled for either a fresh or a frozen embryo transfer on day 3 (cleavage-stage) in both IVF and ICSI cycles; (3) follow-up available up to the end of pregnancy. Exclusion criteria included: (1) simultaneous transfer of embryos from different ovarian stimulation cycles; (2) diagnosis of polycystic ovary syndrome based on the modified Rotterdam diagnostic criteria; (3) diagnosis of intrauterine disease including endometrial polyps or submucosal myomas, as determined by ultrasound or hysteroscopy. Only the first embryo transfer cycles of patients were included for analysis.

In our center, embryo development was evaluated on day 3, and only high-quality cleavage-stage embryos \[at least six blastomeres with ≤20% fragmentation according to the Cummins\' Criteria ([@B14])\] were selected for transfer. In fresh group, all patients were scheduled for a day-3 fresh ET at first, and supernumerary embryos were vitrified. While in the freeze-all group, the entire cohort of good-quality embryos was vitrified on day 3.

There is growing clinical and scientific evidence showing that FET improves outcomes for both the mother and baby, and the major reason currently given for continuing with fresh embryo transfers are patient preference and governmental funding models that discourage a freeze-all strategy as stated by Evans et al. ([@B6]). The freeze-all strategy has been widely used due to its great advantages ([@B15]), and so, many patients receive treatment with all embryos cryopreserved, especially for women with premature P elevation and ovarian hyperstimulation syndrome (OHSS) risk. Notably, the couples received careful counseling regarding protocol of FET and fresh ET. Some couples may consider factors such as the risk in embryo damage after cryopreservation, longer duration of a cycle and more visits to the hospital in the FET cycles. The couples\' opinion regarding transfer performed in fresh or frozen cycle was taken into consideration. Therefore, the final decision between freeze-all strategy and fresh embryo transfer for the first attempt was based on a joint decision by the patient and the doctor.

Statistical Analysis
--------------------

### Propensity Score Matching Procedures

Before propensity score matching, the baseline characteristics distributed between freeze-all and fresh group were not the same. In order to account for this imbalance, a propensity score was generated using a logistic regression model as suggested by Rosenbaum and Rubin ([@B16], [@B17]). A total of 16 covariates were selected for the propensity score model as follows: age, BMI, duration of infertility, gravidity, parity, endocrinological profile (basal FSH, LH, E~2~, P, and AFC), concomitant infertility factors (tubal factors and male factors), procedure, number of oocytes retrieved, number of embryos available, number of embryos transferred. Following propensity score generation, patients were matched by using 1:2 nearest neighbor matching without replacement. Cramer\'s V and R^2^ were used to assess the balance in baseline covariates for categorical variables and continuous variables, respectively, where values closer to zero represent more balance between two groups.

### Outcomes

Our main outcomes included the rates of implantation, clinical pregnancy, and live birth. The implantation rate was calculated as the number of gestational sacs divided by the number of embryos transferred. Clinical pregnancy was defined as the presence of a gestational sac with fetal heart activity in the ultrasound examination. It includes ectopic pregnancy. A miscarriage was defined as the pregnancy loss before 12 weeks of gestation. Live birth was defined as the number of women delivered at least one live neonate. Additionally, subgroup analyses were performed after stratification by the number of oocytes retrieved and fertilization method.

Gestational age was counted from the day of embryo transfer, defined as day 17 of the menstrual cycle. Preterm delivery (delivery at \<37 weeks of gestation), very preterm delivery (delivery at \<32 weeks of gestation),LBW (birth weight \<2,500 g), very LBW (birth weight \<1,500 g), term LBW (LBW at 37 weeks of gestation or greater) and preterm LBW (LBW at \<37 weeks of gestation) were all counted. Additionally, we calculated a birth weight z-score ([@B18]) for each child using the following formula: (weight of individual case at given gestational age---mean weight of reference population at same gestational age)/standard deviation in the reference population, in order to adequately account for the effect of gestational age and newborn gender on birth weight. Two reference populations were used to calculate the birth weight z-scores for singletons ([@B19]) and multiple births ([@B20]) respectively.

### Other Analyses

The chi-squared test or Fisher\'s exact test was used for categorical comparisons as appropriate. The Mann--Whitney--Wilcoxon test was used for continuous variables. The significant difference was considered at *P*-value \<0.05. Data were carried out using the Statistical Package for the Social Sciences software (version 23.0, SPSS Inc., Chicago, USA).

Result {#s3}
======

A total of 1,651 women were extracted from the database in Shanghai Ninth People\'s Hospital affiliated with Shanghai Jiao Tong University School. Patient distribution before and after propensity score matching is shown in [Figure 1](#F1){ref-type="fig"}. After matching, there were 506 women in the freeze-all group and 255 women in fresh group. Main maternal and treatment characteristics of the population before and after propensity score matching are summarized in [Table 1](#T1){ref-type="table"}. After propensity score matching, all the baseline characteristics between the two study groups are balanced.

![Flow chart.](fendo-10-00770-g0001){#F1}

###### 

Main maternal and treatment characteristics before and after matching.

                                        **Unmatched group**   **Propensity score matched group**                                                                        
  ------------------------------------- --------------------- ------------------------------------ -------- -------- ------------------- ------------------- ---------- --------
  **Demographics**                                                                                                                                                      
   Age                                  32.0 (29.0, 35.0)     33.0 (30.0, 35.0)                    0.0017            32.0 (29.0, 35.0)   33.0 (30.0, 35.0)   0.0011     
   BMI                                  20.7 (19.2, 22.4)     20.6 (19.1, 22.3)                    0.0005            20.7 (19.4, 22.3)   20.6 (19.1, 22.3)   \<0.0001   
  **Fertility characteristics**                                                                                                                                         
   Duration of infertility              3.0 (2.0, 5.0)        4.0 (2.0, 6.0)                       0.0130            3.5 (2.0, 6.0)      4.0 (2.0, 6.0)      0.0011     
   Gravidity                            0.0 (0.0, 1.0)        0.0 (0.0, 1.0)                       0.0005            0.0 (0.0, 1.0)      0.0 (0.0, 1.0)      0.0009     
   Parity                               0.0 (0.0, 0.0)        0.0 (0.0, 0.0)                       0.0026            0.0 (0.0, 0.0)      0.0 (0.0, 0.0)      \<0.0001   
  **Concomitant infertility factors**                                                                                                                                   
   Tubal factors                        824 (59.0)            132 (51.8)                                    0.0531   269 (53.2)          132 (51.8)                     0.0132
   Male factors                         227 (16.3)            52 (20.4)                                     0.0398   109 (21.5)          52 (20.4)                      0.0131
  **Endocrinological profile**                                                                                                                                          
   Basal FSH (IU/L)                     5.9 (5.0, 7.3)        5.2 (3.8, 7.0)                       0.0066            5.6 (4.8, 6.7)      5.2 (3.8, 7.0)      0.0016     
   Basal LH (IU/L)                      3.3 (2.4, 4.4)        2.2 (1.2, 3.9)                       0.0002            3.2 (2.4, 4.3)      2.2 (1.2, 3.9)      0.0006     
   Basal E2 (pg/mL)                     36.0 (26.0, 49.0)     31.0 (17.0, 49.0)                    0.0003            36.0 (27.0, 49.3)   31.0 (17.0, 49.0)   \<0.0001   
   Basal P (ng/mL)                      0.3 (0.2, 0.4)        0.2 (0.2, 0.4)                       0.0009            0.3 (0.2, 0.4)      0.2 (0.2, 0.4)      0.0008     
   Antral follicle count                8.0 (5.0, 11.0)       9.0 (6.0, 10.0)                      0.0002            9.0 (5.0, 12.0)     9.0 (6.0, 10.0)     \<0.0001   
  **Procedure**                                                                                                                                                         
   IVF                                  1000 (71.6)           190 (74.5)                                    0.0447   359 (70.9)          190 (74.5)                     0.0378
   ICSI                                 292 (20.9)            54 (21.2)                                              121 (23.9)          54 (21.2)                      
   IVF+ICSI                             104 (7.4)             11 (4.3)                                               26 (5.1)            11 (4.3)                       
  No. of oocytes retrieved              7.0 (4.0, 12.0)       8.0 (5.0, 13.0)                      0.0041            8.0 (4.0, 13.0)     8.0 (5.0, 13.0)     0.0003     
  No. of embryos available              3.0 (2.0, 5.0)        4.0 (2.0, 6.0)                       0.0078            4.0 (2.0, 6.0)      4.0 (2.0, 6.0)      0.0002     
  No. of embryos transferred            2.0 (2.0, 2.0)        2.0 (2.0, 2.0)                       0.0029            2.0 (2.0, 2.0)      2.0 (2.0, 2.0)      0.0007     

*Continuous data are presented as median (interquartile range). Categorical data are presented as n (%)*.

*R^2^used to assess balance in covariates for continuous variables*.

*Cramer\'s V used to assess balance in covariates for categorical variables*.

In our matched cohort ([Table 2](#T2){ref-type="table"}), the implantation, clinical pregnancy and live birth rates were statistically significantly higher in the freeze-all group compared with fresh transfer groups, with OR 1.60 (95% CI, 1.26--2.02; *P* \< 0.001) for implantation, OR 1.69 (95% CI, 1.25--2.30; *P* \< 0.001) for clinical pregnancy, and OR 1.74 (95% CI, 1.27--2.39; *P* \< 0.001) for live birth. No remarkable differences emerged in the rates of biochemical pregnancy, miscarriage, ectopic pregnancy, and multiple births between groups.

###### 

Main pregnancy characteristics.

  ----------------------------------------------------------------------------------------------------
                               **Freeze-all**\   **Fresh**\        ***P*-value**   **OR**\
                               **(*n* = 506)**   **(*n* = 255)**                   **(95% CI)**
  ---------------------------- ----------------- ----------------- --------------- -------------------
  Implantation rate            34.4 (332/964)    25.5 (125/491)    \<0.001         1.60 (1.26--2.02)

  Biochemical pregnancy rate   7.1 (36/506)      6.7 (17/255)      0.813           1.07 (0.59--1.95)

  Clinical pregnancy rate      51.8 (262/506)    38.8 (99/255)     \<0.001         1.69 (1.25--2.30)

  Multiple pregnancy rate      21.0 (55/262)     18.2 (18/99)      0.553           1.20 (0.66--2.16)

  Miscarriage rate             12.2 (32/262)     16.2 (16/99)      0.326           0.72 (0.38--1.38)

  Ectopic pregnancy rate       0.4 (1/262)       1.0 (1/99)        0.490           0.38 (0.02--6.06)

  Live birth rate              45.3 (229/506)    31.8 (82/255)     \<0.001         1.74 (1.27--2.39)
  ----------------------------------------------------------------------------------------------------

*Data are presented as % (n/N). OR, odds ratio; CI, confidence interval*.

Two subgroup analyses were then performed using the propensity matched data set to isolate the effect of the freeze-all strategy. First, patients were stratified based on the number of oocytes retrieved ([Table 3](#T3){ref-type="table"}). The difference in pregnancy outcomes between fresh and freeze-all cycles was not significant in low responders (1--5 OR). However, when women got more than 15 oocytes, the rates of clinical pregnancy (61.6% vs. 21.7%; OR 5.79; 95% CI, 2.49--13.46, *P* \< 0.001) and live birth (57.5% vs. 21.7%; OR 4.88; 95% CI, 2.10--11.30, *P* \< 0.001) were great higher in freeze-all group than in fresh group. Next, the data were analyzed according to the fertilization method. Considering the limited number of IVF+ICSI cycles in our study, we put the ICSI and IVF+ICSI cycles in the same group for analysis. As shown in [Table 4](#T4){ref-type="table"}, CPR and LBR in IVF cycles still significantly differed between the study groups (*P* \< 0.001). For cycles performed with ICSI (including ICSI and IVF+ICSI cycles), there were no statistically significant differences in the selected pregnancy outcomes between freeze-all and fresh groups.

###### 

Pregnancy outcomes according to the number of oocytes retrieved.

                       **Freeze-all**   **Fresh**   **OR (95% CI)**      ***P***
  -------------------- ---------------- ----------- -------------------- ---------
  1--5 (*n* = 237)                                                       
     CPR               75 (44.4)        25 (36.8)   1.37 (0.77--2.45)    0.284
     LBR               61 (36.1)        21 (30.9)   1.26 (0.69--2.31)    0.446
  5--10 (*n* = 243)                                                      
     CPR               83 (55.0)        44 (47.8)   1.33 (0.79--2.24)    0.280
     LBR               73 (48.3)        36 (39.1)   1.46 (0.86--2.47)    0.162
  11--15 (*n* = 162)                                                     
     CPR               59 (52.2)        20 (40.8)   1.58 (0.80--3.12)    0.184
     LBR               53 (46.9)        15 (30.6)   2.00 (0.98--4.08)    0.056
  \>15 (*n* = 119)                                                       
     CPR               45 (61.6)        10 (21.7)   5.79 (2.49--13.46)   \<0.001
     LBR               42 (57.5)        10 (21.7)   4.88 (2.10--11.30)   \<0.001

*Data were presented as n (%). CPR, clinical pregnancy rate; LBR, live birth rate; OR, odds ratio; CI, confidence interval*.

###### 

Pregnancy outcomes according to the fertilization method.

                                                     **Freeze-all**   **Fresh**   **OR (95% CI)**     ***P***
  -------------------------------------------------- ---------------- ----------- ------------------- ----------
  IVF (*n* = 549)                                                                                     
     CPR                                             193 (53.8)       72 (37.9)   1.91 (1.33--2.73)   0.0004
     LBR                                             171 (47.6)       57 (30.0)   2.12 (1.46--3.08)   \<0.0001
  ICSI[^\*^](#TN3){ref-type="table-fn"}(*n* = 212)                                                    
     CPR                                             69 (46.9)        27 (41.5)   1.25 (0.69--2.25)   0.467
     LBR                                             58 (39.5)        25 (38.5)   1.04 (0.57--1.90)   0.891

*Data were presented as n (%). CPR, clinical pregnancy rate; LBR, live birth rate; OR, odds ratio; CI, confidence interval*.

*Including both ICSI and IVF+ICSI cycles*.

Neonatal outcomes are shown in [Table 5](#T5){ref-type="table"}. A total of 382 infants (excluded for 2 vanishing twins) were delivered following 761 embryo transfer cycles, including 236 singletons and 146 multiple births. For all these babies, the mode of delivery, sex of live-born, gestational age, unadjusted median birth weight, z-score, PTD, VPTD, LBW, VLBW, term LBW, and preterm LBW did not differ significantly in two groups.

###### 

Main neonatal outcomes.

                     **Singletons[^\*^](#TN4){ref-type="table-fn"}**   **Multiple births**                                                                   
  ------------------ ------------------------------------------------- ------------------------- ------- ------------------------- ------------------------- -------
  Cesarean section   131 (76.2)                                        47 (73.4)                 0.666   104 (94.5)                36 (100.0)                0.337
  Male sex           95 (55.2)                                         34 (53.1)                 0.772   61 (55.5)                 24 (66.7)                 0.236
  Gestational age    275.0 (269.0, 278.0)                              273.0 (266.0, 279.0)      0.861   259.0 (252.0, 262.0)      257.5 (254.0, 261.0)      0.319
  PTD                15 (8.7)                                          5 (7.8)                   0.824   48 (43.6)                 22 (61.1)                 0.068
  VPTD               2 (1.2)                                           0 (0.0)                   1.000   4 (3.6)                   2 (5.6)                   0.637
  Birth weight       3350.0 (3022.5, 3700.0)                           3250.0 (3000.0, 3500.0)   0.272   2615.0 (2200.0, 2881.3)   2600.0 (2382.5, 2765.0)   0.966
  Z-score            0.03 (−0.54, 0.71)                                −0.30 (−0.72, 0.25)       0.186   −0.03 (−0.76, 0.66)       0.07 (−0.62, 0.74)        0.303
  LBW                10 (5.8)                                          2 (3.1)                   0.521   44 (40.0)                 10 (27.8)                 0.187
  VLBW               1 (0.6)                                           0 (0.0)                   1.000   5 (4.5)                   2 (5.6)                   1.000
  Term LBW           2 (1.2)                                           0 (0.0)                   1.000   13 (11.8)                 4 (11.1)                  1.000
  Preterm LBW        8 (4.7)                                           2 (3.1)                   0.733   35 (31.8)                 8 (22.2)                  0.273

*Excluded for 2 vanishing twins*.

*Continuous data (gestational age, birth weight, and z-score) are presented as median (interquartile range). Categorical data (all other variables) are presented as n (%)*.

Discussion {#s4}
==========

The present study showed that freeze-all strategy led to a significantly higher implantation rate, clinical pregnancy rate and live birth rate compared to fresh ET transfer. Additionally, there was no difference in the outcomes of birth weight or gestational age at delivery when comparing two study groups. To our knowledge, this is the first large retrospective study to compare the fertility and neonatal outcomes of the first embryo transfer cycles following freeze-all strategy vs. fresh transfer in patients with advanced endometriosis.

To date, only two studies were identified to explore the effect of freeze-all strategy in women with endometriosis. A retrospective matched cohort study, including 135 endometriosis-affected women in the fresh ET and deferred ET group, respectively, reported significantly higher cumulative clinical pregnancy rate (43.0% vs. 29.6%) and cumulative ongoing pregnancy rate (34.8% vs. 17.8%) in the deferred ET group compared to the fresh ET group ([@B11]). The other study involving 521 IVF-ET/ICSI cycles in patients with mild endometriosis showed that the early abortion rate (6.7% vs. 14.6%) is lower and the live birth rate (33.7% vs. 28.4%) is higher in the first FET cycle after whole embryo cryopreservation ([@B10]). Nevertheless, the validity of the ([@B21])se results is actually hampered by methodological limitations, since there were some differences persisted in baseline data between the groups, which might have biased the results. Moreover, the literature on advanced endometriosis is limited, and neither of these two studies have reported the neonatal outcomes after freeze-all strategy, which may be partly due to the small sample sizes they had.

Our study, aiming to overcome methodological shortcomings in above-mentioned studies and enrolling a large cohort of patients, demonstrated that for women with advanced endometriosis received freeze-all strategy had a higher percentage of implantation rate, clinical pregnancy rate, and live birth rate relative to fresh cycles. This result was somewhat consistent with several previous randomized controlled trials performed in women not restricted to endometriosis. Shapiro et al. ([@B4]) revealed significantly greater probability of clinical pregnancy with thawed embryos, controlled for differences in embryo quality, when compared with fresh in a cohort of 122 high responders (\>15 antral follicles). A higher frequency of live birth and a lower frequency of pregnancy loss were found after freeze-all strategy in PCOS patients ([@B8]), and in ovulatory women a significantly lower risk of the OHSS was reported in the freeze-all group than in fresh group ([@B9]). Another small randomized controlled trial comparing freeze-all with fresh embryo transfer after preimplantation genetic screening showed the ongoing pregnancy rate (80% vs. 61%) and live birth rate (77% vs. 59%) in the freeze-all group were significantly higher compared with the fresh group ([@B22]).

In the subgroup analysis we found the advantages of freeze-all strategy were becoming more and more significant as the number of oocytes retrieved increased. This result was close to several previous studies. Higher rates of implantation and ongoing pregnancy were reported in freeze-all group than fresh ET group among women with 10--15 oocytes retrieved (OR) but not among those with 4 to 9 oocytes retrieved ([@B23]). A meta-analysis including five randomized controlled trials revealed that the freeze-all strategy could be favorable when high numbers of oocytes are collected, but when the mean number of oocytes collected is \<15, the freeze-all strategy does not appear to be advantageous ([@B24]). Another analysis of 82,935 patient cycles also indicated that the freeze-all strategy is beneficial only in high responders (≥15 OR) but not in intermediate (6--14 OR) or low responders (1--5 OR) ([@B25]). It is interesting to note that although present study got a similar trend as previous studies, the freeze-all policy still had advantages at each OR level compared to fresh ET for advanced endometriosis women. We speculate that the difference is due to the abnormalities of endometrium in patients with III to IV endometriosis, since they usually have a less receptive endometrium than do women with other infertility causes.

When patients were stratified based on the fertilization method, the pregnancy outcome of freeze-all IVF group was still better than that of the fresh group. While in ICSI cycles, the advantage of freeze-all strategy was not obvious. The underlying mechanism for this finding is unclear and likely complex. It is speculated that decreased potential for embryonic development may play a role. A number of previous studies have reported a reduced ability of ICSI-derived embryos to develop to the blastocyst stage *in vitro* ([@B26]--[@B28]). This phenomenon may be associated with the injection procedure rather than with the origin of the male gamete, since it has also been found in a sibling oocyte study ([@B29]). Moreover, the decreased potential for *in vitro* blastocyst formation may be magnified following cryopreservation at early cleavage stages ([@B30]). Therefore, it is not surprising to see that the advantage of FET relative to fresh embryo transfer is limited when ICSI insemination techniques are used to achieve fertilization.

Several studies suggested that birth weight of live born may be higher after FET than those after fresh ET for all infertility women ([@B31], [@B32]). Notably, this difference only appeared in autologous cycles but not in donated cycles ([@B33], [@B34]), suggesting that unfriendly uterine environment before ET may be the main factor contributing to the adverse outcome in fresh cycles. Moreover, a retrospective study showed the incidence of low birth weight increased with increasing number of oocytes retrieved in either fresh or frozen group, which suggested that the supraphysiologic hormonal milieu at the time of oocyte retrieval may also affect the quality of embryos ([@B25]). Nevertheless, in line with our present results, a randomized controlled trial performed in ovulatory patients showed that there was no significant difference in birth weight between freeze-all and fresh groups ([@B9]).

The endometrium of women with endometriosis differs from the endometrium of healthy unaffected women ([@B35]), which may largely account for the decrease in the quality of endometrial receptivity. Therefore, it is of utmost importance to choose the appropriate strategy of embryo transfer, especially for women with advanced endometriosis. A number of studies have reported the impact of ovarian stimulation in fresh ET cycles on the early peri-implantation uterine environment. Firstly, decreased endometrial and subendometrial blood flow have been found in stimulated cycles compared to natural cycles as measured by three-dimensional power Doppler ultrasound ([@B36]). Moreover, some histopathologic changes of the stimulated endometrium have been confirmed, including advancement of endometrial maturation ([@B37]) and premature formation of nucleolar channel systems ([@B38]). In addition, during fresh embryo transfer cycles, the disruptions in the transcriptional activity of genes involved in endometrial receptivity have been proved by several researchers ([@B39]--[@B41]). The aforementioned changes are associated with the hyperestrogenic milieu generated during fresh IVF, which can in turn impair early embryonic adhesion ([@B42]), and, therefore, the implantation potential of embryos. Thus, it is not surprising that in present study the implantation, clinical pregnancy and live birth rates in fresh cycles were lower than rates in freeze-all cycles.

Strengths and Limitations {#s5}
=========================

A main strength of our study is that it included 761 patients with advanced endometriosis over 11 years, which is the largest number study on this topic to-date, offering an opportunity to compare the neonatal outcomes between two embryo transfer strategies. Moreover, we adopted the propensity score matching method, presenting some methodological similarities with randomized controlled trials ([@B43]), to ensure that the two groups are similar in terms of patient characteristics and make outcomes under the matched groups independent of treatment assignment ([@B44]). In addition, we applied a set of rigid inclusion criteria to optimize the quality of data. In order to minimize the influence of endometriosis stages, we merely collected the data of women diagnosed with stage III/IV endometriosis in our center. Since Chinese legislation limited the proportion of blastocyst transfer cycles within 7% to control the male birth, transfer of cleavage-stage embryos remained a priority ([@B8], [@B9]). In this study, we further restricted the analysis to cycles performed in day 3 embryo transfer to eliminate possible effects of culture duration on ART outcomes.

There are also some limitations in this study. First, because this is a retrospective study from a single center, so a well-designed, prospective, randomized study in women with endometriosis is needed in the future. Second, data on smoking history was not available in our database. Considering that only 2.4% of women in China smoke and the rate in infertile patients may be even lower ([@B45]), smoking is not supposed to play a role in the results because of the limited smokers within the study population.

In conclusion, we found that the first transfer in freeze-all strategy resulted in significantly higher rates of implantation, clinical pregnancy and live birth compared with fresh transfer, and the neonatal outcomes were similar between groups, suggesting that freeze-all strategy is an attractive option to improve the outcomes of ART for women with advanced endometriosis.
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